Contact this trialFirst, we need to learn more about you.
Angiotensin Receptor-Neprilysin Inhibitor
LCZ 696 for Type 2 Diabetes
Recruiting2 awardsPhase 2
Rochester, Minnesota
This trial will help researchers learn more about how diabetes affects heart function and whether a new treatment can prevent heart failure in people with diabetes.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.